CClinicalTrials.gg
CompletedNCT01862471Updated Jun 20, 2013

Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow

An interventional study of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Venous Thrombosis, sponsored by National University of Ireland, Galway, Ireland. Completed at 1 site in Ireland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-06-20.

Sponsored by National University of Ireland, Galway, Ireland · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Deep Vein Thrombosis (DVT) is a life threatening condition and a serious concern among hospitalized patients, with death occurring in approximately 6% of cases. It involves the formation of a clot where stagnant blood flow occurs, predominantly in the deep veins of the legs. Three mechanisms underlie DVT, venous stasis (slowing or stopping of the blood), hypercoagulability (increased clotting) and damage to blood vessel endothelium (damage to blood vessel wall), collectively known as Virchow's triad.

Intermittent pneumatic compression (IPC) and neuromuscular electrical stimulation (NMES) have been shown to improve lower limb blood flow. However, few studies have directly compared the two methods and those that have, have used outdated NMES devices.

The objective of this study is to compare the effectiveness of a modern NMES device to intermittent pneumatic compression in terms of blood flow.

02

Conditions studied

  • Venous Thrombosis

Keywords

  • Deep Vein Thrombosis
  • Neuromuscular Electrical Stimulation
  • Intermittent Pneumatic Compression
  • Doppler Ultrasound
03

In context

Thrombosis

1,506 studies on the registry are indexed under Thrombosis; 238 are open to participants now.

This study's enrollment of 30 is below the median of 106 across 849 interventional studies indexed under Thrombosis.

Browse Thrombosis studies →

Lead sponsor

National University of Ireland, Galway, Ireland is the lead sponsor of 46 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

-

Exclusion Criteria:

  • History of heart/respiratory problems
  • Pregnancy
  • Presence of implants, including cardiac pacemakers and orthopaedic implants
  • History of neurological disorder
  • History of severe arterial disease or known dermatological problems
  • Under 18 years of age or over 40 years of age
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    DVT prophylaxis

    Neuromuscular electrical stimulation using a custom-built, two-channel stimulator (Duo-STIM (stimulator), Bioelectronics Research Cluster, National University of Ireland, Galway) with a frequency of 36 Hz, a balanced biphasic waveform with a pulse width of 350μs, a ramp up time of 500ms, a contraction time of 1s and a ramp down time of 500ms. Stimulation was applied every 20 seconds over a period of 5 minutes. Intermittent pneumatic compression using the Novamedix A-V Impulse System Model 6000 (Novamedix distribution Limited, England), programmed to deliver compression every 20 seconds at a pressure of 130 mmHg for a 1 second duration over a period of 5 minutes.

    Device: Neuromuscular Electrical Stimulation · Device: Intermittent Pneumatic Compression

Interventions

  • DeviceNeuromuscular Electrical Stimulation

    Frequency of 36Hz, a balanced biphasic waveform with a pulse width of 350μs, a ramp up time of 500ms, a contraction time of 1s and a ramp down time of 500ms.

    Also known as: Custom-built, two-channel stimulator (Duo-STIM, Bioelectronics Research Cluster, NUI Galway)

  • DeviceIntermittent Pneumatic Compression

    Programmed to deliver compression every 20 seconds at a pressure of 130mmHg for a 1 second duration over a period of 5 minutes.

    Also known as: Novamedix AV Impulse System Model 6000 (Novamedix distribution Limited, England)

06

What researchers measure

Primary outcomes

  1. Blood Flow Measurements from the Lower Limb

    Time frame: An hour and a half (plus or minus half an hour)

Secondary outcomes

  1. Blood Pressure

    Time frame: An hour and a half (plus or minus half an hour)

  2. Heart Rate

    Time frame: An hour and a half (plus or minus half an hour)

07

Study locations

1 site
  • National University of Ireland, Galway
    Galway, Ireland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 20, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01862471
Lead sponsor
National University of Ireland, Galway, Ireland
Collaborators
Irish Research Council
Responsible party
Gearoid O Laighin (Professor, National University of Ireland, Galway, Ireland) — Principal investigator
First posted
May 24, 2013
Start date
May 2013
Primary completion
Jun 2013
Completion
Jun 2013
Last update
Jun 20, 2013

Study contacts

Gearoid OLaighin, PhD
principal investigator · National University of Ireland, Galway

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion